Episode
Rasonque Shows Promise for Lung Cancer | Baton Rouge News
- Published
- Sep 4, 2026
- Duration seconds
- 81
- Processing state
not_requested- Canonical source
- https://sources.thednn.ai/3b7ee998cc400d89
Actions
POST https://stenobird.com/v1/public/podcasts/baton-rouge-news-today-2-min-news-the-daily-news-now-7575259/episodes/rasonque-shows-promise-for-lung-cancer-baton-rouge-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/baton-rouge-news-today-2-min-news-the-daily-news-now-7575259/rasonque-shows-promise-for-lung-cancer-baton-rouge-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
A groundbreaking new drug, Rasonque, just got FDA approval for pancreatic cancer—and it’s already showing major promise in early lung cancer trials. Targeting notorious RAS proteins, it doubled survival rates in pancreatic patients and is now being fast-tracked for lung cancer, the world’s top cancer killer. While side effects like rashes and stomach issues exist, early results are encouraging. More trials are underway, and if they hold up, this could be a game-changer for millions. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/3b7ee998cc400d89